English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Australian OGTR consults on GM wheat field trial from CSIROqrcode

May. 1, 2018

Favorites Print
Forward
May. 1, 2018
The Australia’s Gene Technology Regulator is currently assessing licence application DIR 162 from CSIRO. The application from CSIRO is for a field trial (limited and controlled release) of wheat genetically modified for enhanced rust disease resistance. The purpose of the field trial is to assess the agronomic characteristics of the GM wheat plants under field conditions.

The trial is proposed to take place in the ACT and the Hilltops Council area in NSW over five growing seasons between September 2018 and September 2023. The proposal is to plant up to 40 m2 in total in each growing season. The GM wheat grown in this field trial would not be used in human food or animal feed.

A consultation Risk Assessment and Risk Management Plan (RARMP) has been prepared, which concludes that the proposed release would pose negligible risk to human health and safety or to the environment. A range of draft licence conditions would limit the size, locations and duration of the release, as well as restrict the spread and persistence of the GMOs and the introduced genetic material.

The Regulator welcomes written submissions in order to finalise the RARMP, which will then inform the decision on whether or not to issue the licence. The consultation RARMP and related documents can be obtained from the OGTR website under What’s New or by contacting the Office. Please quote application DIR 162 in any correspondence.


Submissions should be received by close of business on 12 June 2018.
Source: OGTR

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox